Safety, Tolerability and PK 3-Period Crossover Study Comparing 2 Single Doses of ZTI-01 and Monurol® in Healthy Subjects

NCT02178254 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

NIH

Sponsor class

Conditions

Pseudomonas Infection

Interventions

DRUG: Fosfomycin tromethamine
DRUG: Fosfomycin disodium

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)